Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Amicus Therapeutics Stock Price (Quote) NASDAQ:FOLD
$10.52 ( 0.19% ) Monday, 25th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $9.41 | $11.98 | Monday, 25th Oct 2021 FOLD stock ended at $10.52. This is 0.19% more than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 3.31% from a day low at $10.27 to a day high of $10.61. |
| 90 days | $8.64 | $12.11 | |
| 52 weeks | $8.60 | $25.39 |
Historical Amicus Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-25 | $10.46 | $10.61 | $10.27 | $10.52 | 1 413 942 |
| 2021-10-22 | $10.50 | $10.59 | $10.24 | $10.50 | 3 189 287 |
| 2021-10-21 | $10.76 | $10.87 | $10.51 | $10.52 | 2 146 064 |
| 2021-10-20 | $10.86 | $11.05 | $10.71 | $10.76 | 1 205 517 |
| 2021-10-19 | $10.71 | $10.98 | $10.69 | $10.85 | 1 075 188 |
| 2021-10-18 | $10.99 | $11.16 | $10.68 | $10.70 | 1 795 258 |
| 2021-10-15 | $11.70 | $11.70 | $11.08 | $11.08 | 2 757 352 |
| 2021-10-14 | $11.55 | $11.60 | $11.24 | $11.49 | 1 665 491 |
| 2021-10-13 | $11.84 | $11.86 | $11.36 | $11.42 | 1 211 327 |
| 2021-10-12 | $11.69 | $11.98 | $11.60 | $11.84 | 2 425 368 |
| 2021-10-11 | $11.42 | $11.79 | $11.33 | $11.67 | 2 323 796 |
| 2021-10-08 | $11.24 | $11.58 | $11.15 | $11.51 | 2 756 409 |
| 2021-10-07 | $10.97 | $11.49 | $10.74 | $11.24 | 4 097 339 |
| 2021-10-06 | $9.91 | $10.98 | $9.91 | $10.93 | 3 554 534 |
| 2021-10-05 | $9.92 | $10.22 | $9.88 | $10.10 | 3 622 064 |
| 2021-10-04 | $10.10 | $10.15 | $9.65 | $9.82 | 2 090 360 |
| 2021-10-01 | $9.58 | $10.25 | $9.41 | $10.19 | 3 747 609 |
| 2021-09-30 | $10.09 | $10.16 | $9.51 | $9.55 | 6 614 073 |
| 2021-09-29 | $11.25 | $11.25 | $9.63 | $9.66 | 13 045 015 |
| 2021-09-28 | $10.65 | $10.65 | $10.15 | $10.18 | 1 787 373 |
| 2021-09-27 | $10.89 | $10.92 | $10.73 | $10.74 | 1 332 976 |
| 2021-09-24 | $11.03 | $11.06 | $10.86 | $10.87 | 1 195 224 |
| 2021-09-23 | $10.83 | $11.14 | $10.77 | $11.10 | 1 230 470 |
| 2021-09-22 | $11.07 | $11.08 | $10.81 | $10.83 | 1 051 299 |
| 2021-09-21 | $10.98 | $11.17 | $10.94 | $11.02 | 1 656 274 |
| 2021-09-20 | $10.77 | $11.19 | $10.73 | $10.98 | 1 915 337 |
| 2021-09-17 | $11.13 | $11.16 | $10.70 | $11.00 | 6 557 975 |
| 2021-09-16 | $11.09 | $11.18 | $10.91 | $11.08 | 1 221 930 |
| 2021-09-15 | $10.82 | $11.19 | $10.82 | $11.14 | 1 841 335 |
| 2021-09-14 | $11.37 | $11.42 | $10.67 | $10.82 | 2 823 353 |
| 2021-09-13 | $11.04 | $11.43 | $10.90 | $11.27 | 1 728 092 |
| 2021-09-10 | $11.57 | $11.57 | $10.92 | $10.93 | 1 961 785 |
| 2021-09-09 | $11.45 | $11.72 | $11.39 | $11.48 | 2 069 394 |
| 2021-09-08 | $11.41 | $11.46 | $11.16 | $11.39 | 1 165 642 |
| 2021-09-07 | $11.55 | $11.72 | $11.24 | $11.38 | 1 900 916 |
| 2021-09-03 | $11.61 | $12.11 | $11.47 | $11.63 | 2 156 992 |
| 2021-09-02 | $11.66 | $11.85 | $11.52 | $11.84 | 1 782 224 |
| 2021-09-01 | $11.27 | $11.70 | $11.21 | $11.68 | 1 442 506 |
| 2021-08-31 | $11.28 | $11.46 | $11.25 | $11.39 | 2 196 320 |
| 2021-08-30 | $11.27 | $11.44 | $11.22 | $11.30 | 1 885 038 |
| 2021-08-27 | $10.90 | $11.37 | $10.82 | $11.26 | 1 455 838 |
| 2021-08-26 | $11.03 | $11.32 | $10.83 | $10.86 | 1 692 115 |
| 2021-08-25 | $10.89 | $11.15 | $10.77 | $11.09 | 1 700 453 |
| 2021-08-24 | $10.76 | $10.97 | $10.65 | $10.89 | 967 324 |
| 2021-08-23 | $10.55 | $11.07 | $10.51 | $10.76 | 1 794 063 |
| 2021-08-20 | $10.19 | $10.59 | $10.18 | $10.54 | 1 752 310 |
| 2021-08-19 | $10.09 | $10.35 | $10.00 | $10.21 | 1 372 729 |
| 2021-08-18 | $10.60 | $10.60 | $10.19 | $10.20 | 1 461 447 |
| 2021-08-17 | $10.17 | $10.59 | $10.11 | $10.57 | 1 249 773 |
| 2021-08-16 | $10.35 | $10.42 | $10.18 | $10.22 | 2 093 006 |
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, a small molecule, which has completed Phase III studies that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease. The company is also developing SD-101, which is in Phase III clinical s... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
